Reveals how overvaluation influences the quality and likelihood of non-GAAP earnings disclosures in firms, indicating important implications for investors.
Purpose This study investigates the relations between overvalued equity and the likelihood and quality of a non-GAAP earnings disclosure. Design/methodology/approach Using alternative measures of non-GAAP earnings quality that include the magnitude of the disclosure and its exclusion persistence, this study employs multivariate regression analyses to evaluate the associations between overvalued firms and the likelihood and quality of a non-GAAP disclosure. Findings Results of tests show that the likelihood (quality) of a non-GAAP disclosure increases (decreases) with overvaluation. Our results are robust to alternative proxies for overvaluation, non-GAAP disclosure quality, and endogeneity tests. We find that these results may be extended to highly valued firms more generally. Originality/value In light of the rise in firms' propensities to report non-GAAP earnings, a growing body of research has investigated factors related to the quality of these disclosures. This research extends these studies by investigating the questions of how overvaluation affects the likelihood and quality of a non-GAAP disclosure.
No takes yet. Share an insight, caveat, or question.
Houmes et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: